共 42 条
- [38] Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany—a health insurance claims data analysis; [Therapiepersistenz unter realen Bedingungen bei Patienten mit rheumatoider Arthritis nach Beginn einer DMARD-Therapie – eine Analyse von Abrechnungsdaten der Krankenversicherungen in Deutschland] Zeitschrift für Rheumatologie, 2023, 82 (9) : 739 - 753
- [39] Indirect costs of absenteeism due to rheumatoid arthritis, psoriasis, multiple sclerosis, insulin-dependent diabetes mellitus, and ulcerative colitis in 2012: a study based on real-life data from the Social Insurance Institution in Poland EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (02) : 295 - 303